Submitted by Anonymous (not verified) on 14 July 2026 - 8:53
Opinion/decision on a Paediatric investigation plan (PIP): Imcivree, setmelanotide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Metabolism and nutrition disorders, PIP number: EMA/PE/0000245434
Source: